About Perosphere

This startup develops a point-of-care coagulometer that performs coagulation tests on fresh or citrated whole blood, enabling real-time monitoring of anticoagulant activity and their antidotes. By providing immediate and accurate diagnostic results, healthcare professionals can make timely decisions that enhance patient care and outcomes.

```xml <problem> Current coagulation testing methods often require central lab analysis, leading to delays in obtaining results and hindering timely clinical decision-making, especially in point-of-care settings. The need for reagents and specialized training further complicates rapid and accessible coagulation assessment. </problem> <solution> Perosphere Technologies offers the ClotChek, a point-of-care coagulometer designed for rapid assessment of a patient's coagulation status using fresh or citrated whole blood. This handheld, battery-powered device provides a global view of coagulation in 3-8 minutes, enabling immediate treatment decisions. The ClotChek utilizes a reagent-free assay, simplifying the testing process and reducing the potential for errors. Its lab-like precision and low variability ensure reliable results at the patient's bedside. </solution> <features> - Point-of-care, handheld coagulometer for rapid testing - Reagent-free assay, simplifying the testing process - Provides a global view of coagulation status - Results available in 3-8 minutes - Low variability, ensuring lab-like precision - Suitable for use with fresh or citrated whole blood - WBCT Assay: Single-use assay stable at room temperature - Liquid Quality Controls: Two levels available (normal and anticoagulated) </features> <target_audience> The primary users are healthcare professionals in hospitals, emergency rooms, and point-of-care settings who require rapid and accurate coagulation assessment for timely treatment decisions. </target_audience> ```

What does Perosphere do?

Where is Perosphere located?

Perosphere is based in Danbury, United States.

How much funding has Perosphere raised?

Perosphere has raised 21960000.

Location

Danbury, United States

Funding

21960000

Employees

28 employees

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

Perosphere

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

perospheretech.com 700+

Danbury, United States

Funding

Estimated Funding

$20M+

Team (25+)

No team information available.

Company Description

Problem

Current coagulation testing methods often require central lab analysis, leading to delays in obtaining results and hindering timely clinical decision-making, especially in point-of-care settings. The need for reagents and specialized training further complicates rapid and accessible coagulation assessment.

Solution

Perosphere Technologies offers the ClotChek, a point-of-care coagulometer designed for rapid assessment of a patient's coagulation status using fresh or citrated whole blood. This handheld, battery-powered device provides a global view of coagulation in 3-8 minutes, enabling immediate treatment decisions. The ClotChek utilizes a reagent-free assay, simplifying the testing process and reducing the potential for errors. Its lab-like precision and low variability ensure reliable results at the patient's bedside.

Features

Point-of-care, handheld coagulometer for rapid testing

Reagent-free assay, simplifying the testing process

Provides a global view of coagulation status

Results available in 3-8 minutes

Low variability, ensuring lab-like precision

Suitable for use with fresh or citrated whole blood

WBCT Assay: Single-use assay stable at room temperature

Liquid Quality Controls: Two levels available (normal and anticoagulated)

Target Audience

The primary users are healthcare professionals in hospitals, emergency rooms, and point-of-care settings who require rapid and accurate coagulation assessment for timely treatment decisions.